Keyphrases
Pyruvate Cycle
88%
Type 2 Diabetes Mellitus (T2DM)
69%
Hepatic Insulin Resistance
53%
Non-alcoholic Fatty Liver Disease (NAFLD)
48%
Anaplerosis
44%
Gain-of-function mutation
44%
Lipid Homeostasis
44%
Low Dose Rate
44%
Liver Transplant Recipients
44%
ATP Synthesis
44%
Ablation
44%
Mitochondrial Metabolism
44%
Insulin Resistance
44%
Low-density Lipoprotein Receptor-related Protein 5 (LRP5)
44%
Propionate
44%
Mitochondrial Oxidation
44%
Hypophosphatemia
44%
Glucose Homeostasis
44%
Growth Hormone Treatment
44%
Pleotropic Effects
44%
Leptin Replacement Therapy
44%
Nonalcoholic Steatohepatitis
44%
Liver
41%
Inorganic Phosphate
38%
Knock-in Mouse Model
33%
Pyruvate Kinase
29%
Glucagon
29%
GH Replacement Therapy
26%
Diacylglycerol
20%
Insulin Sensitivity
20%
High Bone Mass
18%
Physiologic
18%
N-acetyltransferase 2 (NAT2)
17%
PKC Activation
17%
Craniopharyngioma
17%
Whole-body
17%
Hepatic Steatosis
17%
GH Deficiency
17%
Pediatric Patients
17%
Medicine and Dentistry
Insulin Resistance
100%
Nonalcoholic Fatty Liver
66%
Maturity Onset Diabetes of the Young
60%
Metabolic Syndrome
53%
Brain Cell
44%
Leptin
44%
Pediatrics
44%
Liver Graft
44%
Diabetic Ketoacidosis
44%
Growth Hormone
44%
Microbiome
44%
Gain of Function Mutation
44%
Gut Microbiota
44%
Lipoprotein Receptor
44%
Glucose Homeostasis
44%
Lipid Homeostasis
44%
Acetic Acid
44%
Hypopituitarism
44%
Sequela
31%
Substitution Therapy
26%
Non-Alcoholic Fatty Liver Disease
26%
4 Iodo 2,5 Dimethoxyamphetamine
26%
Insulin Release
25%
Bone Mass
18%
Craniopharyngioma
17%
Recurrent Disease
17%
Growth Hormone Deficiency
17%
Pediatrics Patient
17%
Liver Cirrhosis
17%
Fatty Liver
17%
Biochemistry, Genetics and Molecular Biology
Mitochondrial Respiration
88%
Nuclear Magnetic Resonance Spectroscopy
47%
Anaplerosis
44%
LDL Receptor
44%
N-Acetyltransferase 1
44%
Blood Plasma
44%
Glucose Homeostasis
44%
Lipoprotein Receptor-Related Protein
44%
Gluconeogenesis
44%
Lipid Homeostasis
44%
Gain of Function Mutation
44%
Insulin Resistance
44%
Hypophosphatemia
44%
Adenosine Triphosphate
44%
Arylamine N-Acetyltransferase
44%
Glutamic Acid
35%
Knockout Mouse
23%
Glucagon
22%
Pyruvate Kinase
22%
Liquid Chromatography-Mass Spectrometry
22%
Metabolic Pathway
17%
Bone Mass
17%
Insulin Sensitivity
16%
Lipid Storage
15%
